⌘K

Login Start Free

Home/Filings/4/0000899243-22-003469

4//SEC Filing

Kearns Evan 4

Accession 0000899243-22-003469

CIK 0001622229other

View on SEC.gov Company Profile

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 5:42 PM ET

Size

5.5 KB

Accession

0000899243-22-003469

Insider Transaction Report

Form 4

Period: 2022-01-25

Cogent Biosciences, Inc.COGT

Chief Legal Officer

Transactions

Award
Stock Option (Right to Buy)
2022-01-25$4.94/sh+202,250$999,762→ 202,250 total
Exercise: $7.60Exp: 2032-01-25→ Common Stock (202,250 underlying)

Footnotes (1)

[F1]This stock option shall vest in equal monthly installments over a four year period.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cogent Biosciences, Inc.

CIK 0001622229

Entity typeother

Related Parties

1

filerCIK 0001745285

Filing Metadata

Form type: 4
Filed: Jan 26, 7:00 PM ET
Accepted: Jan 27, 5:42 PM ET
Size: 5.5 KB

View on SEC.gov